Пређи на садржај

Периоперативна нега

Економски резултати

Greater than sevenfold return on investment for a comprehensive patient blood management program with equivalent or improved outcomes. (отвара нови прозор)

Frank SM, Hensley NB, Thomas AJ, Dawson CG, Resar LMS, Ulatowski JA, Crowe EP

Извор‎: Anesth Analg 2024;138(6):1345-48.

Индекс‎: PubMed 38530909

DOI‎: 10.1213/ANE.0000000000006862

https://pubmed.ncbi.nlm.nih.gov/38530909/ (отвара нови прозор)

Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. (отвара нови прозор)

Frank SM, Wick EC, Dezern AE, Ness PM, Wasey JO, Pippa AC, Dackiw E, Resar LM.

Извор‎: Transfusion 2014;54(10 Pt 2):2668-77.

Индекс‎: PubMed 24942198

DOI‎: 10.1111/trf.12752

https://www.ncbi.nlm.nih.gov/pubmed/24942198 (отвара нови прозор)

Economic considerations on transfusion medicine and patient blood management. (отвара нови прозор)

Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A.

Извор‎: Best Pract Res Clin Anaesthesiol 2013;27(1):59-68.

Индекс‎: PubMed 23590916

DOI‎: 10.1016/j.bpa.2013.02.001

https://www.ncbi.nlm.nih.gov/pubmed/23590916 (отвара нови прозор)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (отвара нови прозор)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Извор‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Индекс‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (отвара нови прозор)

Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. (отвара нови прозор)

LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, Rich JB, Kasirajan V, Fonner E Jr, Kron IL, Speir AM; Investigators for the Virginia Cardiac Surgery Quality Initiative.

Извор‎: J Thorac Cardiovasc Surg 2013;145(3):796-804.

Индекс‎: PubMed 23414992

DOI‎: 10.1016/j.jtcvs.2012.12.041

https://www.ncbi.nlm.nih.gov/pubmed/23414992 (отвара нови прозор)

Associations between preoperative anaemia and hospital costs following major abdominal surgery: cohort study. (отвара нови прозор)

Meyerov J, Louis M, Lee DK, Fletcher L, Banyasz D, Miles LF, Ma R, Tosif S, Koshy AN, Story DA, Bellomo R, Weinberg L

Извор‎: BJS Open 2021;5(2):zraa070.

Индекс‎: PubMed 33834189

DOI‎: 10.1093/bjsopen/zraa070

https://pubmed.ncbi.nlm.nih.gov/33834189/ (отвара нови прозор)

A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation. (отвара нови прозор)

Phillips SD, Maguire D, Deshpande R, Muiesan P, Bowles MJ, Rela M, Heaton ND.

Извор‎: Transplantation 2006;81(4):536-40.

Индекс‎: PubMed 16495800

DOI‎: 10.1097/01.tp.0000199318.17013.c5

https://www.ncbi.nlm.nih.gov/pubmed/16495800 (отвара нови прозор)

Effective reduction of blood product use in a community teaching hospital: when less is more. (отвара нови прозор)

Politsmakher A, Doddapaneni V, Seeratan R, Dosik H.

Извор‎: Am J Med 2013;126(10):894-902.

Индекс‎: PubMed 24054957

DOI‎: 10.1016/j.amjmed.2013.06.013

https://www.ncbi.nlm.nih.gov/pubmed/24054957 (отвара нови прозор)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (отвара нови прозор)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Извор‎: Transfusion 2010;50(2):487-92.

Индекс‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (отвара нови прозор)

Activity-based costs of blood transfusions in surgical patients at four hospitals. (отвара нови прозор)

Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR.

Извор‎: Transfusion 2010;50(4):753-65.

Индекс‎: PubMed 20003061

DOI‎: 10.1111/j.1537-2995.2009.02518.x

https://www.ncbi.nlm.nih.gov/pubmed/20003061 (отвара нови прозор)

Implementation of a comprehensive patient blood management program for hospitalized patients at a large united states medical center. (отвара нови прозор)

Warner MA, Schulte PJ, Hanson AC, Madde NR, Burt JM, Higgins AA, Andrijasevic NM, Kreuter JD, Jacob EK, Stubbs JR, Kor DJ

Извор‎: Mayo Clin Proc. 2021;96(12):2980-90.

Индекс‎: PubMed 34736775

DOI‎: 10.1016/j.mayocp.2021.07.017

https://pubmed.ncbi.nlm.nih.gov/34736775/ (отвара нови прозор)

The volume of returned red blood cells in a large blood salvage program: where does it all go? (отвара нови прозор)

Waters JH, Dyga RM, Waters JF, Yazer MH.

Извор‎: Transfusion 2011;51(10):2126-32.

Индекс‎: PubMed 21985047

DOI‎: 10.1111/j.1537-2995.2011.03111.x

https://www.ncbi.nlm.nih.gov/pubmed/21985047 (отвара нови прозор)

An economic analysis of costs associated with development of a cell salvage program. (отвара нови прозор)

Waters JR, Meier HH, Waters JH.

Извор‎: Anesth Analg 2007;104(4):869-75.

Индекс‎: PubMed 17377098

DOI‎: 10.1213/01.ane.0000258039.79028.7c

https://www.ncbi.nlm.nih.gov/pubmed/17377098 (отвара нови прозор)